Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A cash back credit card cap sets a limit on how much cash back you can earn. Understanding this cap is crucial for effective budgeting and maximizing rewards.
23,435 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Starting with $1,000 can jumpstart a lasting investing habit. This guide shows practical ways to pick the best stocks...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
Tesla stock has swung wildly in recent years, prompting timing questions. This guide explains what 'late' means for T...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
When a CEO with Nvidia’s clout announces a partner could be the next trillion-dollar company, investors listen. This ...
Many retirees focus on saving enough, but the real danger lies in how that money flows. This guide reveals the bigges...
A $900,000 retirement on Florida’s Gulf Coast could work with disciplined housing costs, insurance planning, and care...
Kick off your week with a concise, practical set of market notes. This Tuesday reads guide blends data, strategy, and...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...